🔥 Wednesday 29 October 2025 Wed, 29 Oct 2025

Locate Technologies reports a 19% revenue increase in its Locate2u segment and progresses toward a December 2025 NZX listing, supported by new board appointments and a NZD 10 million ATM facility.

Cash Converters has successfully completed the institutional component of a $25 million equity raising, positioning itself to acquire 29 franchise stores and expand its retail footprint.

Austco Healthcare kicks off FY26 with a robust 51% revenue increase and improved profitability, driven by strong organic growth and strategic acquisitions.

Ballard Mining accelerates exploration at its fully permitted Mt Ida Gold Project, revealing a substantial new exploration target alongside a robust existing resource base.

Ballard Mining has raised $20.6 million through a premium share placement led by new strategic investor Aurenne Group Holdings, aiming to accelerate exploration and resource growth at its Mt Ida Gold Project. A new, substantial October 2025 Exploration Target highlights significant upside beyond the existing mineral resources.

Power Minerals Limited has advanced its critical minerals portfolio with the acquisition of the Gamma Heavy Rare Earths and Uranium Project in California and completed the Santa Anna Niobium-REE-Gallium Project acquisition in Brazil, supported by a combined $6.7 million capital raise.

Archer Materials has successfully demonstrated that its blood potassium Biochip can be fabricated on a silicon platform, matching clinical accuracy standards and accelerating its path to commercialisation.

Boss Energy reports a record quarterly uranium production at its Honeymoon Project, with costs coming in below FY26 guidance and a robust cash position. The company also announces a leadership change as Matthew Dusci takes the helm as CEO.

Artemis Resources has reported a significant high-grade gold intersection in its maiden drill hole at the Titan East Prospect, signalling promising expansion potential near its Carlow resource.

Pursuit Minerals progresses its Rio Grande Sur lithium project with a refined commercial plan and feasibility study, while expanding into gold through the Sascha Marcelina acquisition. A recent $4 million placement strengthens its financial position for growth.

IRIS Metals’ Phase II drilling at the Tin Mountain Project confirms exceptional lithium grades and unveils critical minerals like rubidium, positioning the company as a key player in the US critical minerals landscape.

Australian Rare Earths Limited (ASX, AR3) reported strong progress in its Koppamurra Rare Earths Project with high recovery rates and production milestones, while also expanding and resuming drilling at its Overland Uranium Project. The company bolstered its financial position through government grants and option exercises.

PhosCo Ltd reports a significant 50.5m phosphate intersection at its KM prospect in Tunisia, reinforcing strong project economics and prompting a potential acceleration of production schedules.

Alligator Energy has commenced construction of its pivotal Samphire Field Recovery Trial, marking a significant shift from exploration to development. The company also bolstered its leadership team to support this growth phase and reported promising exploration results at its Big Lake Uranium Project.

Dundas Minerals has leveraged advanced AI technology to identify multiple high-priority gold targets beneath shallow cover in its Gerry Well Greenstone Belt tenements, signaling a promising new chapter in its exploration journey.

Cazaly Resources has identified anomalous gold mineralisation over a 700-metre strike at its Goongarrie Gold Project, prompting an expanded aircore drilling campaign to explore further along the Menzies Shear Zone.

Terra Metals has reported multiple new zones of massive and semi-massive sulfide mineralisation at its Southwest Prospect within the Dante Project, signalling a potentially large-scale, multi-metal magmatic system. Assay results are pending as drilling and geophysical surveys continue.

Dreadnought Resources has upgraded its scoping study for the Star of Mangaroon gold project, increasing the initial production target by 24% to approximately 24,700 ounces at 8.3 g/t gold, while halving the maximum cash drawdown to $5.4 million.

Odyssey Gold Limited has reported significant progress on its Tuckanarra Gold Project, including a positive Mining Technical Study, robust drilling results, and a $4 million capital raise to fund ongoing exploration and development.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

Latrobe Magnesium successfully commissioned its Demonstration Plant producing magnesium oxide and secured $10 million in funding, while receiving a $200 million financing interest from the U.S. Export Import Bank for its next-stage commercial plant.

INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.